← Leaderboards
Klaus Ãberla
Universitatsklinikum Erlangen
$277,064
Attributed
$277,064
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $178K · FY2018–19$200K$150K$100K$50K$0
'18
'19
Funding mix
By agency
NIH$277,064 · 1
By mechanism
R21$277,064 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAnimal ModelAnimalsAntibodiesAntibody ResponseBaseBiologicalBloodCandidate SelectionCellsClinical DevelopmentClinical EfficacyComparative EfficacyComplexCostDoseDrug Or Chemical Tissue DistributionEfficacy StudyEfficacy TestingEfficacy TrialEpidemicExperimental StudyFc ReceptorActive Immunization
Grant awards (2)
Global panel of non-human primate challenge viruses for standardized assessment of in vivo efficacy of HIV-1 Env antibodies$178,041
R21 · FY2019 · AI · contact PI
Global panel of non-human primate challenge viruses for standardized assessment of in vivo efficacy of HIV-1 Env antibodies$99,023
R21 · FY2018 · AI · contact PI